Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Radisson Announces Positive Preliminary Economic Assessment for O’Brien Gold Project July 9, 2025 Homerun Resources Inc. Announces Receipt of a Competitive Budgetary Offer for Latin America’s First Dedicated Solar Glass Manufacturing Facility July 9, 2025 Copper Soars to All-Time High as Trump Unveils 50 percent Tariff on Imports July 9, 2025
Homerun Resources Inc. Announces Receipt of a Competitive Budgetary Offer for Latin America’s First Dedicated Solar Glass Manufacturing Facility July 9, 2025
